Brian J. Donnelly's most recent trade in Myriad Genetics, Inc. was a trade of 226,804 Common Stock done . Disclosure was reported to the exchange on March 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Myriad Genetics Inc | Brian J. Donnelly | Chief Commerical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 226,804 | 624,338 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics Inc | Brian J. Donnelly | Chief Commerical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 269,905 | 269,905 (0%) | 0% | 0 | Common Stock | |
| Myriad Genetics Inc | Brian J. Donnelly | Chief Commerical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 236,167 | 236,167 | - | - | Performance-Based Restricted Stock Units | |
| Myriad Genetics Inc | Brian J. Donnelly | Chief Commerical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 127,629 | 397,534 (0%) | 0% | 0 | Common Stock |